The convergence of medicarpin-associated targets within PI3K/AKT/mTOR, MAPK, and apoptosis-related signalling pathways highlights their ability to modulate critical oncogenic pathways that control tumour growth, survival, and treatment resistance in CCA [6,17,19]. This evidence concerns the gene PIK3CA and cholangiocarcinoma.